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Abstract
The goal of this study was to assess the presence of enterococci species presenting van-mediated glycopeptide
resistance in French cattle. Fecal samples were collected from healthy and sick animals, and enterococci were
screened for vancomycin resistance. Vancomycin resistance was principally encountered in Enterococcus galli-
narum and Enterococcus casseliflavus strains. However, glycopeptide resistance was detected in three different
species of enterococci (E. faecalis, E. faecium, and E. casseliflavus). Molecular characterization of the genetic
support proved that they all presented the prototypic VanA element. Interestingly, the E. casseliflavus strain
displayed a remarkable VanB phenotype=vanA-vanC genotype. Transferability, associated resistances, and fac-
tors of vanA cotransfer were sought. This study proved that acquired vanA genes can still be detected in food-
producing animals more than a decade after the avoparcin ban. Indeed, calves, which are recurrently exposed to
antibiotics in France, may allow the re-emergence of glycopeptide resistance through coselection factors, and this
might potentially be concerning for human health.
Introduction
Glycopeptide antibiotics such as vancomycin andteicoplanin are used in the treatment of severe infections
caused by Gram-positive bacteria. Enterococci constitute one
of the target species, and the emergence ofAU1c glycopeptide-
resistantEnterococcus faecium (GRE), inEurope in 1988 (Leclercq
et al., 1988; Uttley et al., 1988) and soon afterward in the United
States (Sahm et al., 1989), has become of high clinical concern
(Bonten et al., 2001). However, the transfer of the van genes to
multiresistant Staphylococcus aureus also represents a major
threat, as sporadically reported in the United States since 2002.
Different mechanisms of glycopeptide resistance were de-
scribed in enterococci (Courvalin, 2006). High-level acquired
resistance is principally mediated by the vanA gene world-
wide and to a lesser extent by the vanB gene, which confer a
transferable and inducible resistance to both vancomycin and
teicoplanin or vancomycin only, respectively. These genes are
located on transposons, allowing the intra- and interspecies
spread of resistance.
Enterococci that most widely colonize food-producing an-
imals, Enterococcus gallinarum and Enterococcus casseliflavus,
display the intrinsic and chromosomally encoded vanC gene
that confers a nontransferable low-level glycopeptide resis-
tance. However, enterococci harboring transferable van genes
were also detected, and even became of high concern when
they spread among poultry and pigs (Bonten et al., 2001).
Retrospectively, the use of the glycopeptide avoparcin as a
growth promoter in Europe was suspected to have selected
high-level GRE. With regard to the possible expansion of the
GRE reservoir in animals, whichmight constitute a risk for the
human population, avoparcin was banned in all European
countries in 1997.
Despite the ban, GRE in pigs and poultry were regularly
reported. However, GRE isolated from cattle were scarcely
described worldwide (Bonten et al., 2001). In this study, we
describe the first vanA-presenting Enterococcus faecalis and
Enterococcus faecium isolated from cattle in France. Moreover,
we also report an E. casseliflavus VanB=vanA-vanC isolate,
which is to our knowledge the first case of such a complex
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phenotype–genotype association described in food-producing
animals.
Materials and Methods
Bacterial isolates
The presence of GRE was assessed by analyzing feces of
healthy or sick animals (calves, young beef cattle, and cull
cows) in the frame of two studies. First, enterococci were
isolated from healthy animals randomly sampled at the time
of slaughter during a 2-year (2003–2004) survey, conducted as
part of the National Surveillance Program monitored by the
French Ministry of Agriculture. Enterococci isolates were
sought using the Slanetz and Bartley selective medium (S&B;
Oxoid, Dardilly, France). Second, samples from diarrheic
bovines collected in separate farms were analyzed in 2006, in
partnership with three peripheral veterinary laboratories, as
part of a study on the presence of digestive GRE. After en-
richment in peptone broth, colonies were selected on S&B
containing 6 mg=mL vancomycin.
All GRE (n¼ 26) were characterized on the basis of colony
morphology, API20 Strep test (Biome´rieux, Marcy l’Etoile,
France), and species-specific polymerase chain reaction (PCR)
(Ke et al., 1999; Depardieu et al., 2004; Jackson et al., 2004).
Antimicrobial susceptibility testing
Antibiotic resistance was determined by disk diffusion
following the recommendations of the Antibiogram Com-
mittee of the French Society forMicrobiology (CA-SFM, 2007a,
2007b). The following antibiotics were tested: ampicillin, strep-
tomycin, gentamicin, kanamycin, vancomycin, teicoplanin,
erythromycin, lincomycin, spiramycin, pristinamycin, tetracy-
cline, cotrimoxazole (trimethoprim 25mgþ sulfamethoxazole
23.7mg), florfenicol, enrofloxacin, and bacitracin. Vancomycin
and teicoplanin minimum inhibitory concentrations (MICs)
were determined by E-test according to the manufacturer’s
instructions (AB Biodisk, Solna, Sweden) on Mu¨ller-Hinton
agar (Biome´rieux), following the resistance breakpoints of the
CA-SFM (>8mg=mL for both glycopeptides). E. faecalisAU2c ATCC
29212 was used as a quality-control strain. The phenotypic
copper resistance of selected isolates was tested on plates con-
taining 0, 4, 8, 12, 16, 20, 24, 28, and 32mM copper sulfate as
described by Hasman et al. (2006).
Molecular analyses
The van genes were detected by PCR using specific primers
as described (Depardieu et al., 2004). The VanA elements were
analyzed by restriction fragment length polymorphism and
restriction analysis as previously described (Palepou et al.,
1998), using theAU2c CIP 103510 as vanA-positive control strain.
Point mutations were sought in vanX by restriction poly-
morphism, or in vanS by sequencing. The Tn1546 was ana-
lyzed by PCR as described by Oh et al. (2007). The presence of
the copper-resistance gene tcrB (Hasman and Aarestrup,
2002) and the postsegregational killing system (PSK) (Sorum
et al., 2006) were investigated by PCR as described byHasman
and Aarestrup and Sorum et al., respectively.
Pulsed-field gel electrophoresis
All vanC E. gallinarum and E. casseliflavus were character-
ized by pulsed-field gel electrophoresis (PFGE) after digestion
by SmaI, according to Garnier et al. (2004) with minor modi-
fications. Parameters for electrophoresis for both strains were
6V=cm at 148C for 22 h, with pulse time ramps from 0.5 to
15 sec. Differences in PFGE patterns were assessed visually.
Transferability of resistance
Transferability of the vanA-mediated resistance was tested
by filter and broth mating as described (Lester et al., 2006),
using E. faecalis JH2-2 as the recipient. For the filter mating,
100 mL of the donor and recipient strains were mixed and
placed on a sterile 0.45 mm pore filter on Columbia agar
complemented with 5% sheep blood (COS; AES Chemunex,
Bruz, France). After 24 h of incubation at 378C, bacteria were
resuspended in NaCl 0.9%, and appropriate dilutions of bac-
teria were plated on COS agar containing rifampicin, fusidic
acid, and vancomycin as selection antibiotics. Transconju-
gants were observed after 24–48 h of incubation at 378C.
Conjugation was validated by PCR detection of the vanA gene
on five colonies randomly picked on the selective plate. For
broth mating, 0.5mL of donor and recipient strains were in-
cubated in 4.5mL of Luria-Bertani broth. Selection was per-
formed as for the filter mating. Transfer frequencies were
expressed as the number of transconjugants per donor cell, and
the data reported were the average of three different trials.
Results
A total of 1503 fecal samples were analyzed, 917 coming
from the survey on healthy cattle and 536 from diarrheic bo-
vines. In the survey, 218 enterococcal isolates were detected
(recovery rate, 22.5%), among which 9 were GRE (9=967, 1%).
In parallel, 17 GRE (17=536, 3.2%) were directly recovered
from the sick animals.
Eight E. casseliflavus harboring the vanC2 gene and 15 E.
gallinarum with the vanC1 gene were isolated ( bT1Table 1). Seven
out of these 8 E. casseliflavus were recovered from healthy an-
imals, while 14 out of the 15 E. gallinarum came from sick cattle.
PFGE profiles showed no genetic relatedness (data not shown).
In parallel, three strains presented the GRE phenotype
(Table 1).
E. faecalisH356_2was isolated from a healthy calf in 2003 at
the Chapin slaughterhouse, Ille-et-Vilaine. The strain pre-
sented a high-level resistance to vancomycin and teicoplanin
(MICs >256mg=L), and the vanA gene was detected. Addi-
tional resistances to kanamycin, erythromycin, lincomycin,
spectinomycin, pristinamycin, tetracycline, and cotrimox-
azole were identified as well.
E. faecium S8346 was isolated from a diarrheic calf on farm
in Moselle, in 2006. High-level resistance to vancomycin and
teicoplanin (MIC >256mg=L) coincided with the presence of
the vanA gene. S8346 strain also displayed resistances to
ampicillin, streptomycin, kanamycin, erythromycin, linco-
mycin, spectinomycin, tetracycline, and enrofloxacin.
E. casseliflavus S8702 was isolated from a diarrheic calf in
Seine-Maritime, in 2006. This strain presented a VanB phe-
notype (high-level vancomycin resistance [MIC > 256mg=L]
and susceptibility to teicoplanin [MIC¼ 3mg=L]), associated
with a vanA=vanC2 genotype. No additional antibiotic resis-
tance was associated, but the tcrB gene was detected. The
presence of this gene conferred a slightly reduced suscepti-
bility to copper, since bacterial growthwas observed on plates
containing 11mM of copper, instead of 6mM for the E. faecalis
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AU2c ATCC 29212 reference strain. Moreover, the PSK system was
also identified by PCR.
PCR amplification followed by enzymatic digestion indi-
cated that all three strains presented an element similar to the
prototypic Tn1546 described by Palepou et al. (1998). The se-
quential PCR on the Tn1546 performed according to Oh
et al. (2007) led to the same amplification for the three vanA-
containing strains as well as for theAU2c CIP 103510 control strain.
The vanRSHAX genes were further detailed by sequencing of
the vanS gene, and by restriction analysis of vanX with the
DdeI enzyme. No mutations were detected in the vanS and
vanX genes, and the length of the PCR fragments showed no
major genetic rearrangements, demonstrating the conserva-
tion of the vanRSHAX organization.
Transferability of the vanA-mediated resistance was tested,
but could not be detected from S8346 and S8702 strains
(frequency <108 per donor cell). Conversely, H356_2 trans-
ferred the vanA determinant at a frequency of 4104 trans-
conjugants per donor. Only cotrimoxazole cotransferred with
the vanA gene.
Discussion
In this study, both intrinsic vanC-mediated and acquired
vanA-mediated resistances were detected in enterococci iso-
lated from French cattle.
The presence of E. gallinarum and E. casseliflavus harboring
the vanC gene was expected in cattle. However, surprisingly,
E. gallinarumwere nearly all isolated from sick cattle, whereas
E. casseliflavus mainly came from healthy carriers. Yet, all
isolates came from different farms and, according to their
nonidentical PFGE patterns, should not have spread clonally.
This discrepancy has never been reported before and thus
remains unexplained. Therefore, further investigations on
sick and healthy cattle would be needed, and particularly on
samples collected in a same period of time. On the other hand,
the nontransferability of the vanC elements, and the low-level
resistance conferred, usually leads to a lack of interest for
these species. Yet, this might change with the emergence of
vanA-vanC genotypes as described in human (Camargo et al.,
2004) and now in cattle (E. casseliflavus S8702), as well as with
the recent report of vanA-vanC1 E. gallinarum in human
(Merquior et al., 2008).
Three GRE were also described here. They were recovered
from different species (E. faecalis, E. faecium, and E. casseli-
flavus), but all presented the prototypic Tn1546 and conserved
vanRSHAX genes.
The E. faecalis H356_2 showed a high transfer rate—
proving the dissemination capacities of the VanA element, but
no cotransfer of erythromycin and=or tetracycline resistance
was observed. This stands in partial contradiction with the
Table 1. Species, Genotypes, and Antimicrobial Resistance of Glycopeptide-Resistant
Enterococcus faecium Strains Isolated From Cattle
Strains Species Genotypea
MICsb (mg=L)
Additional resistancesVancomycin Teicoplanin
Healthy animals
H95 Enterococcus casseliflavus vanC2 8 1.5 L
H236 E. casseliflavus vanC2 8 1.5 L
H344 E. casseliflavus vanC2 6 2 L, E
H402 E. casseliflavus vanC2 8 2 L, Tc
H430 E. casseliflavus vanC2 6 2 L
H447 E. casseliflavus vanC2 6 1.5 L
H537 E. casseliflavus vanC2 8 1.5 L, E, Sp, Tc
H143 Enterococcus gallinarum vanC2 16 1.5 L
H356_2 Enterococcus faecalis vanA >256 >256 L, E, Sp, K, Pt, SXT, Tc
Sick animals
S8552 E. gallinarum vanC1 12 1.5 L, B
S8555 E. gallinarum vanC1 12 1.5 L, B, Sp
S8556 E. gallinarum vanC1 8 1.5 L
S8557 E. gallinarum vanC1 12 1.5 L
S8561 E. gallinarum vanC1 12 1.5 L, Rif
S8565 E. gallinarum vanC1 12 1.5 L
S8568 E. gallinarum vanC1 12 1.5 L
S8569 E. gallinarum vanC1 12 1.5 L
S8570 E. gallinarum vanC1 8 1 L, B
S8572 E. gallinarum vanC1 12 1.5 L, B
S8573 E. gallinarum vanC1 12 1.5 L
S8698 E. gallinarum vanC1 12 1.5 L, B
S8700 E. casseliflavus vanC1 8 1.5 L
S8703 E. gallinarum vanC1 12 1.5 L, B
S9011 E. gallinarum vanC1 16 1.5 L, B
S8346 E. faecium vanA >256 >256 Am, Sm, L, E, Sp, Tc, K, Enr
S8702 E. casseliflavus vanC2, vanA >256 3 –
avan-specific PCRs were validated using reference strains (two).
bMICs were systematically performed on the required quality-control strains.
MICs, minimum inhibitory concentrations; Am, ampicillin; B, bacitracin; Enr, enrofloxacin; E, erythromycin; K, kanamycin; L, lincomycin;
Pt, pristinamycin; Rif, rifampicin; Sp, spiramycin; Sm, streptomycin; SXT, cotrimoxazole; Tc, tetracycline; PCR, polymerase chain reaction.
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hypothesis that persistence of vancomycin resistance is due to
coselection through the use of these antibiotic classes (Aar-
estrup, 2000). Yet, coselection might occur through the use of
other antimicrobials such as cotrimoxazole, which is the un-
ique antibiotic that cotransferred with vanA in our experi-
mental setting. It is also to note that cotrimoxazole is the
second most widely used drug after tetracyclines in veteri-
nary medicine in France. However, whether the cotransfer of
the VanA-element might occur through another mechanism
than antibiotic coselection cannot be excluded. Further, hori-
zontal transfer of the van genes between poultry and cattle
should not be underestimated when different animal species
are reared within the same farm.
The E. faecium S8346 displayed multiple antibiotic resis-
tances associatedwith the prototypic VanA element. Globally,
the presence of multiresistant strains should be monitored,
irrespective of the presence of van genes, since they might
narrow the already small therapeutic arsenal against En-
terococcus spp. Yet, resistance to tetracycline andmacrolides—
which was also detected in the E. faecalisH356_2 strain as well
as in three E. casseliflavus and one E. gallinarum—was not
unexpected. Indeed, these antibiotic families are still used for
the treatment and prevention of disease, and such entero-
coccal resistances have already been reported in cattle or food
products (meat and milk) (MARAN, 2005; Jung et al., 2007;
Kaszanyitzky et al., 2007). On the contrary, the detection of
beta-lactam resistance was of higher concern because ampi-
cillin remains the first-line treatment in human.
Finally, the E. casseliflavus S8702 presented the complex
VanB=vanA-vanC pattern. Phenotype–genotype discrepancies
have already been reported in human enterococci (Song et al.,
2006). Likewise, the vanA-vanC genotype has been described
in human E. gallinarum and E. casseliflavus (Dutka-Malen et al.,
1994; Camargo et al., 2004), but, to our knowledge, such a com-
plex association had never been described in an E. casseliflavus
isolated from animals. Moreover, no VanSmutations or major
genetic rearrangements of the Tn1546 can explain the mech-
anism of the VanB phenotype in the vanA genetic background
(Song et al., 2006). Similarly, no detectable insertion or dele-
tion in the Tn1546 was detected, thus leaving this specific
phenotype–genotype association unexplained, as already
described in E. faecium (Gu et al., 2009). As mentioned above,
S8702 also harbors the tcrB and PSK system genes. On the one
hand, copper sulfate, which is used as an additive, was shown
to act as a selective factor of conjugation and transfer of the
resistance to glycopeptide and macrolides (Hasman and
Aarestrup, 2002), and tcr genes were already detected in
E. casseliflavus isolated from pigs (Hasman et al., 2006). On the
other hand, it has been suggested that PSK systems might be
involved in the long-term persistence of vanA-containing
plasmids in E. faecium isolated from poultry. However, the
true relevance of these mechanisms is still debated (Hasman
and Aarestrup, 2005; Sorum et al., 2006).
In conclusion, we isolated three different species of en-
terococci presenting a vanA-mediated glycopeptide resistance
in cattle. Even if both studies were not conducted over the
same period of time, the global prevalence of GRE (3=1503;
0.2%) is obviously not significant. However, one should note
that all three strains were isolated from calves, both in healthy
and sick contexts. In France, calves are recurrently exposed to
antibiotics and, by far, harbor the most elevated resistance
among cattle, including to extended-spectrum beta-lactamases
(Madec et al., 2008). Therefore, despite the ban of avoparcin
usage since 1997, it remains crucial to prevent any GRE re-
emergence in food-producing animals, that is, in calves, but
also in broilers and pigs (Kempf et al., 2008), that would now
result from the use of other antibiotics than glycopeptides.
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